<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Gyger J</submitter><funding>Swiss National Science Foundation</funding><funding>Howard Hughes Medical Institute</funding><funding>NIAID NIH HHS</funding><funding>HHS | NIH | National Institute of Allergy and Infectious Diseases</funding><funding>Howard Hughes Medical Institute (HHMI)</funding><pagination>e0141924</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11253642</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>15(7)</volume><pubmed_abstract>&lt;i>Pseudomonas aeruginosa&lt;/i> encodes the beta-lactamase AmpC, which promotes resistance to beta-lactam antibiotics. Expression of &lt;i>ampC&lt;/i> is induced by anhydro-muropeptides (AMPs) released from the peptidoglycan (PG) cell wall upon beta-lactam treatment. AmpC can also be induced via genetic inactivation of PG biogenesis factors such as the endopeptidase DacB that cleaves PG crosslinks. Mutants in &lt;i>dacB&lt;/i> occur in beta-lactam-resistant clinical isolates of &lt;i>P. aeruginosa&lt;/i>, but it has remained unclear why DacB inactivation promotes &lt;i>ampC&lt;/i> induction. Similarly, the inactivation of lytic transglycosylase (LT) enzymes such as SltB1 that cut PG glycans has also been associated with &lt;i>ampC&lt;/i> induction and beta-lactam resistance. Given that LT enzymes are capable of producing</pubmed_abstract><journal>mBio</journal><pubmed_title>A potential space-making role in cell wall biogenesis for SltB1and DacB revealed by a beta-lactamase induction phenotype in &lt;i>Pseudomonas aeruginosa&lt;/i>.</pubmed_title><pmcid>PMC11253642</pmcid><funding_grant_id>R01 AI083365</funding_grant_id><funding_grant_id>U19 AI158028</funding_grant_id><funding_grant_id>162073</funding_grant_id><pubmed_authors>Bernhardt TG</pubmed_authors><pubmed_authors>Gyger J</pubmed_authors><pubmed_authors>Cava F</pubmed_authors><pubmed_authors>Torrens G</pubmed_authors><pubmed_authors>Fumeaux C</pubmed_authors></additional><is_claimable>false</is_claimable><name>A potential space-making role in cell wall biogenesis for SltB1and DacB revealed by a beta-lactamase induction phenotype in &lt;i>Pseudomonas aeruginosa&lt;/i>.</name><description>&lt;i>Pseudomonas aeruginosa&lt;/i> encodes the beta-lactamase AmpC, which promotes resistance to beta-lactam antibiotics. Expression of &lt;i>ampC&lt;/i> is induced by anhydro-muropeptides (AMPs) released from the peptidoglycan (PG) cell wall upon beta-lactam treatment. AmpC can also be induced via genetic inactivation of PG biogenesis factors such as the endopeptidase DacB that cleaves PG crosslinks. Mutants in &lt;i>dacB&lt;/i> occur in beta-lactam-resistant clinical isolates of &lt;i>P. aeruginosa&lt;/i>, but it has remained unclear why DacB inactivation promotes &lt;i>ampC&lt;/i> induction. Similarly, the inactivation of lytic transglycosylase (LT) enzymes such as SltB1 that cut PG glycans has also been associated with &lt;i>ampC&lt;/i> induction and beta-lactam resistance. Given that LT enzymes are capable of producing</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Jul</publication><modification>2025-04-04T15:01:37.164Z</modification><creation>2025-04-04T15:01:37.164Z</creation></dates><accession>S-EPMC11253642</accession><cross_references><pubmed>38920394</pubmed><doi>10.1128/mbio.01419-24</doi></cross_references></HashMap>